🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

A Cluster Package Intervention to Promote an Evidence-based Use of PSA-tests in General Practice

RecruitingNAAges any - anyAllUniversity of Copenhagen
NCT06748456 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

It is widely acknowledged that prostate specific antigen (PSA) testing can lead to false-positives, overdiagnosis and overtreatment of prostate cancer. The current national clinical guidelines only recommend the test to a small group of patients and does not recommend neither systematic nor opportunistic screening for prostate cancer with the test. The aim of this cluster randomized trial is to evaluate the effectiveness of a complex intervention aimed at improving the use of evidence based practice when using prostate specific antigen tests in general practice. The complex intervention in this study is a so called cluster package which is meeting material to a quality cluster meeting as almost every general practitioner is a member of a quality cluster. Therefore, the investigators have developed a cluster package aimed at promoting an evidence-based use of the prostate specific antig

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Quality clusters with a cluster coordinator * Quality clusters willing to participate in a cluster meeting with PSA as a theme in 2025. Exclusion Criteria: * Quality clusters who already planned their cluster meetings in 2025. * Quality clusters unwilling to await allocation before planning their cluster meetings in 2025. * Quality clusters participating in the pilot study
💊

What it tests

  • Podcast
  • Cluster meeting
  • Hand-out material 1
  • Hand-out material 2
📍

Where

1 site
Center of General Practice, Department of Public Health, University of Copenhagen
Copenhagen, Denmark
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy